HEADER TRANSFERASE/TRANSFERASE INHIBITOR 27-MAY-15 5BO2 TITLE BIANTHRANILATE-LIKE INHIBITOR WITH 4-ATOM "LINE" AND PHOSPHONATE TITLE 2 "HOOK" FISHING FOR HYDROGEN BOND DONORS IN MYCOBACTERIUM TUBERCULOSIS TITLE 3 ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE (ANPRT; TRPD) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.4.2.18; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 419947; SOURCE 4 STRAIN: ATCC 25177 / H37RA; SOURCE 5 GENE: TRPD, MRA_2208; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: C41(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET23A KEYWDS LOBENZARIT-LIKE ANALOGUE, TB STRUCTURAL GENOMICS CONSORTIUM, TBSGC, KEYWDS 2 MAGNESIUM BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.L.EVANS,E.N.BAKER,J.S.LOTT,TB STRUCTURAL GENOMICS CONSORTIUM AUTHOR 2 (TBSGC) REVDAT 3 27-SEP-23 5BO2 1 REMARK REVDAT 2 01-JAN-20 5BO2 1 REMARK REVDAT 1 01-JUN-16 5BO2 0 JRNL AUTH G.L.EVANS,E.N.BAKER,J.S.LOTT JRNL TITL BINDING AND MIMICKING OF THE PHOSPHATE-RICH SUBSTRATE, PRPP. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.96 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 47156 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 2294 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.9755 - 4.8193 1.00 3284 173 0.1635 0.1686 REMARK 3 2 4.8193 - 3.8257 1.00 3217 162 0.1530 0.1886 REMARK 3 3 3.8257 - 3.3423 1.00 3246 153 0.1690 0.2114 REMARK 3 4 3.3423 - 3.0368 1.00 3211 165 0.2000 0.2278 REMARK 3 5 3.0368 - 2.8191 1.00 3216 171 0.2033 0.2379 REMARK 3 6 2.8191 - 2.6529 1.00 3199 169 0.2046 0.2486 REMARK 3 7 2.6529 - 2.5201 1.00 3208 161 0.1991 0.2870 REMARK 3 8 2.5201 - 2.4104 1.00 3202 174 0.2075 0.2791 REMARK 3 9 2.4104 - 2.3176 1.00 3202 149 0.2057 0.2461 REMARK 3 10 2.3176 - 2.2376 1.00 3187 162 0.2059 0.2908 REMARK 3 11 2.2376 - 2.1677 1.00 3177 173 0.2170 0.2590 REMARK 3 12 2.1677 - 2.1057 1.00 3152 174 0.2349 0.2879 REMARK 3 13 2.1057 - 2.0503 1.00 3196 161 0.2550 0.2998 REMARK 3 14 2.0503 - 2.0002 0.98 3165 147 0.2764 0.3237 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.560 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4960 REMARK 3 ANGLE : 0.774 6766 REMARK 3 CHIRALITY : 0.028 786 REMARK 3 PLANARITY : 0.004 894 REMARK 3 DIHEDRAL : 12.415 1693 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5BO2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000210225. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-MAR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS NOVEMBER 3, 2014 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.3.11 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47170 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 47.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.12100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.85600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6 REMARK 200 STARTING MODEL: PDB ENTRY 3QR9 CHAIN A REMARK 200 REMARK 200 REMARK: FLAT-DIAMOND SHAPE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M IMIDAZOLE-MALATE, 9% PEG-4000, REMARK 280 PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 47.23350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.01950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 47.23350 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 39.01950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 593 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 VAL A 1 REMARK 465 ALA A 2 REMARK 465 LEU A 3 REMARK 465 SER A 4 REMARK 465 ALA A 5 REMARK 465 GLU A 6 REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 SER A 9 REMARK 465 GLY A 10 REMARK 465 GLY A 11 REMARK 465 SER A 12 REMARK 465 ARG A 13 REMARK 465 GLY A 14 REMARK 465 GLY A 15 REMARK 465 SER A 16 REMARK 465 PRO A 17 REMARK 465 LYS A 18 REMARK 465 ALA A 19 REMARK 465 GLU A 20 REMARK 465 ALA A 21 REMARK 465 ALA A 22 REMARK 465 SER A 23 REMARK 465 VAL A 24 REMARK 465 PRO A 25 REMARK 465 GLY A 110 REMARK 465 ASP A 111 REMARK 465 GLY A 112 REMARK 465 VAL A 113 REMARK 465 ASN A 114 REMARK 465 ALA A 141 REMARK 465 SER A 142 REMARK 465 SER A 143 REMARK 465 LEU A 144 REMARK 465 SER A 145 REMARK 465 GLY A 146 REMARK 465 ARG A 333 REMARK 465 ALA A 334 REMARK 465 ILE A 370 REMARK 465 LEU A 371 REMARK 465 GLU A 372 REMARK 465 HIS A 373 REMARK 465 HIS A 374 REMARK 465 HIS A 375 REMARK 465 HIS A 376 REMARK 465 HIS A 377 REMARK 465 HIS A 378 REMARK 465 MET B 0 REMARK 465 VAL B 1 REMARK 465 ALA B 2 REMARK 465 LEU B 3 REMARK 465 SER B 4 REMARK 465 ALA B 5 REMARK 465 GLU B 6 REMARK 465 GLY B 7 REMARK 465 SER B 8 REMARK 465 SER B 9 REMARK 465 GLY B 10 REMARK 465 GLY B 11 REMARK 465 SER B 12 REMARK 465 ARG B 13 REMARK 465 GLY B 14 REMARK 465 GLY B 15 REMARK 465 SER B 16 REMARK 465 PRO B 17 REMARK 465 LYS B 18 REMARK 465 ALA B 19 REMARK 465 GLU B 20 REMARK 465 ALA B 21 REMARK 465 ALA B 22 REMARK 465 SER B 23 REMARK 465 VAL B 24 REMARK 465 ASP B 111 REMARK 465 GLY B 112 REMARK 465 VAL B 113 REMARK 465 ASN B 114 REMARK 465 SER B 143 REMARK 465 LEU B 144 REMARK 465 ALA B 290 REMARK 465 GLY B 291 REMARK 465 GLY B 292 REMARK 465 ILE B 370 REMARK 465 LEU B 371 REMARK 465 GLU B 372 REMARK 465 HIS B 373 REMARK 465 HIS B 374 REMARK 465 HIS B 375 REMARK 465 HIS B 376 REMARK 465 HIS B 377 REMARK 465 HIS B 378 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 100 CG OD1 OD2 REMARK 470 VAL A 116 CG1 CG2 REMARK 470 ARG A 157 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 223 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 285 CG CD OE1 NE2 REMARK 470 ASP A 287 CG OD1 OD2 REMARK 470 GLU A 335 CG CD OE1 OE2 REMARK 470 GLN A 369 CG CD OE1 NE2 REMARK 470 SER B 145 OG REMARK 470 ARG B 157 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 163 CG OD1 OD2 REMARK 470 ARG B 194 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 225 CG OD1 OD2 REMARK 470 ARG B 238 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 295 CG CD OE1 NE2 REMARK 470 ARG B 333 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 335 CG CD OE1 OE2 REMARK 470 LEU B 337 CG CD1 CD2 REMARK 470 ARG B 365 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 369 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASN B 56 O HOH B 501 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 73 101.22 91.70 REMARK 500 THR A 257 -168.38 -171.94 REMARK 500 ALA B 73 97.98 96.21 REMARK 500 ASP B 251 47.47 -88.83 REMARK 500 THR B 257 -161.44 -171.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7P1 A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IMD A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IMD A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7P1 B 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IMD B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IMD B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IMD B 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3QR9 RELATED DB: PDB REMARK 900 3QR9 CONTAINS THE SAME PROTEIN WITH NO LIGANDS BOUND AND WAS USED REMARK 900 IN MR FOR THIS STRUCTURE REMARK 900 RELATED ID: 4IJ1 RELATED DB: PDB REMARK 900 4IJ1 CONTAINS THE PARENT INHIBITOR (I.E. WITHOUT THE PHOSPHONATE " REMARK 900 FISHING LINE") BOUND TO THE SAME PROTEIN REMARK 900 RELATED ID: 5BO3 RELATED DB: PDB DBREF 5BO2 A 2 370 UNP A5U4M0 TRPD_MYCTA 2 370 DBREF 5BO2 B 2 370 UNP A5U4M0 TRPD_MYCTA 2 370 SEQADV 5BO2 MET A 0 UNP A5U4M0 INITIATING METHIONINE SEQADV 5BO2 VAL A 1 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 LEU A 371 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 GLU A 372 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 HIS A 373 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 HIS A 374 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 HIS A 375 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 HIS A 376 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 HIS A 377 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 HIS A 378 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 MET B 0 UNP A5U4M0 INITIATING METHIONINE SEQADV 5BO2 VAL B 1 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 LEU B 371 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 GLU B 372 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 HIS B 373 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 HIS B 374 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 HIS B 375 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 HIS B 376 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 HIS B 377 UNP A5U4M0 EXPRESSION TAG SEQADV 5BO2 HIS B 378 UNP A5U4M0 EXPRESSION TAG SEQRES 1 A 379 MET VAL ALA LEU SER ALA GLU GLY SER SER GLY GLY SER SEQRES 2 A 379 ARG GLY GLY SER PRO LYS ALA GLU ALA ALA SER VAL PRO SEQRES 3 A 379 SER TRP PRO GLN ILE LEU GLY ARG LEU THR ASP ASN ARG SEQRES 4 A 379 ASP LEU ALA ARG GLY GLN ALA ALA TRP ALA MET ASP GLN SEQRES 5 A 379 ILE MET THR GLY ASN ALA ARG PRO ALA GLN ILE ALA ALA SEQRES 6 A 379 PHE ALA VAL ALA MET THR MET LYS ALA PRO THR ALA ASP SEQRES 7 A 379 GLU VAL GLY GLU LEU ALA GLY VAL MET LEU SER HIS ALA SEQRES 8 A 379 HIS PRO LEU PRO ALA ASP THR VAL PRO ASP ASP ALA VAL SEQRES 9 A 379 ASP VAL VAL GLY THR GLY GLY ASP GLY VAL ASN THR VAL SEQRES 10 A 379 ASN LEU SER THR MET ALA ALA ILE VAL VAL ALA ALA ALA SEQRES 11 A 379 GLY VAL PRO VAL VAL LYS HIS GLY ASN ARG ALA ALA SER SEQRES 12 A 379 SER LEU SER GLY GLY ALA ASP THR LEU GLU ALA LEU GLY SEQRES 13 A 379 VAL ARG ILE ASP LEU GLY PRO ASP LEU VAL ALA ARG SER SEQRES 14 A 379 LEU ALA GLU VAL GLY ILE GLY PHE CYS PHE ALA PRO ARG SEQRES 15 A 379 PHE HIS PRO SER TYR ARG HIS ALA ALA ALA VAL ARG ARG SEQRES 16 A 379 GLU ILE GLY VAL PRO THR VAL PHE ASN LEU LEU GLY PRO SEQRES 17 A 379 LEU THR ASN PRO ALA ARG PRO ARG ALA GLY LEU ILE GLY SEQRES 18 A 379 CYS ALA PHE ALA ASP LEU ALA GLU VAL MET ALA GLY VAL SEQRES 19 A 379 PHE ALA ALA ARG ARG SER SER VAL LEU VAL VAL HIS GLY SEQRES 20 A 379 ASP ASP GLY LEU ASP GLU LEU THR THR THR THR THR SER SEQRES 21 A 379 THR ILE TRP ARG VAL ALA ALA GLY SER VAL ASP LYS LEU SEQRES 22 A 379 THR PHE ASP PRO ALA GLY PHE GLY PHE ALA ARG ALA GLN SEQRES 23 A 379 LEU ASP GLN LEU ALA GLY GLY ASP ALA GLN ALA ASN ALA SEQRES 24 A 379 ALA ALA VAL ARG ALA VAL LEU GLY GLY ALA ARG GLY PRO SEQRES 25 A 379 VAL ARG ASP ALA VAL VAL LEU ASN ALA ALA GLY ALA ILE SEQRES 26 A 379 VAL ALA HIS ALA GLY LEU SER SER ARG ALA GLU TRP LEU SEQRES 27 A 379 PRO ALA TRP GLU GLU GLY LEU ARG ARG ALA SER ALA ALA SEQRES 28 A 379 ILE ASP THR GLY ALA ALA GLU GLN LEU LEU ALA ARG TRP SEQRES 29 A 379 VAL ARG PHE GLY ARG GLN ILE LEU GLU HIS HIS HIS HIS SEQRES 30 A 379 HIS HIS SEQRES 1 B 379 MET VAL ALA LEU SER ALA GLU GLY SER SER GLY GLY SER SEQRES 2 B 379 ARG GLY GLY SER PRO LYS ALA GLU ALA ALA SER VAL PRO SEQRES 3 B 379 SER TRP PRO GLN ILE LEU GLY ARG LEU THR ASP ASN ARG SEQRES 4 B 379 ASP LEU ALA ARG GLY GLN ALA ALA TRP ALA MET ASP GLN SEQRES 5 B 379 ILE MET THR GLY ASN ALA ARG PRO ALA GLN ILE ALA ALA SEQRES 6 B 379 PHE ALA VAL ALA MET THR MET LYS ALA PRO THR ALA ASP SEQRES 7 B 379 GLU VAL GLY GLU LEU ALA GLY VAL MET LEU SER HIS ALA SEQRES 8 B 379 HIS PRO LEU PRO ALA ASP THR VAL PRO ASP ASP ALA VAL SEQRES 9 B 379 ASP VAL VAL GLY THR GLY GLY ASP GLY VAL ASN THR VAL SEQRES 10 B 379 ASN LEU SER THR MET ALA ALA ILE VAL VAL ALA ALA ALA SEQRES 11 B 379 GLY VAL PRO VAL VAL LYS HIS GLY ASN ARG ALA ALA SER SEQRES 12 B 379 SER LEU SER GLY GLY ALA ASP THR LEU GLU ALA LEU GLY SEQRES 13 B 379 VAL ARG ILE ASP LEU GLY PRO ASP LEU VAL ALA ARG SER SEQRES 14 B 379 LEU ALA GLU VAL GLY ILE GLY PHE CYS PHE ALA PRO ARG SEQRES 15 B 379 PHE HIS PRO SER TYR ARG HIS ALA ALA ALA VAL ARG ARG SEQRES 16 B 379 GLU ILE GLY VAL PRO THR VAL PHE ASN LEU LEU GLY PRO SEQRES 17 B 379 LEU THR ASN PRO ALA ARG PRO ARG ALA GLY LEU ILE GLY SEQRES 18 B 379 CYS ALA PHE ALA ASP LEU ALA GLU VAL MET ALA GLY VAL SEQRES 19 B 379 PHE ALA ALA ARG ARG SER SER VAL LEU VAL VAL HIS GLY SEQRES 20 B 379 ASP ASP GLY LEU ASP GLU LEU THR THR THR THR THR SER SEQRES 21 B 379 THR ILE TRP ARG VAL ALA ALA GLY SER VAL ASP LYS LEU SEQRES 22 B 379 THR PHE ASP PRO ALA GLY PHE GLY PHE ALA ARG ALA GLN SEQRES 23 B 379 LEU ASP GLN LEU ALA GLY GLY ASP ALA GLN ALA ASN ALA SEQRES 24 B 379 ALA ALA VAL ARG ALA VAL LEU GLY GLY ALA ARG GLY PRO SEQRES 25 B 379 VAL ARG ASP ALA VAL VAL LEU ASN ALA ALA GLY ALA ILE SEQRES 26 B 379 VAL ALA HIS ALA GLY LEU SER SER ARG ALA GLU TRP LEU SEQRES 27 B 379 PRO ALA TRP GLU GLU GLY LEU ARG ARG ALA SER ALA ALA SEQRES 28 B 379 ILE ASP THR GLY ALA ALA GLU GLN LEU LEU ALA ARG TRP SEQRES 29 B 379 VAL ARG PHE GLY ARG GLN ILE LEU GLU HIS HIS HIS HIS SEQRES 30 B 379 HIS HIS HET 7P1 A 400 27 HET IMD A 401 5 HET IMD A 402 5 HET 7P1 B 400 27 HET IMD B 401 5 HET IMD B 402 5 HET IMD B 403 5 HETNAM 7P1 2-[(2-CARBOXYPHENYL)AMINO]-5-(3-PHOSPHONOPROPOXY) HETNAM 2 7P1 BENZOIC ACID HETNAM IMD IMIDAZOLE FORMUL 3 7P1 2(C17 H18 N O8 P) FORMUL 4 IMD 5(C3 H5 N2 1+) FORMUL 10 HOH *352(H2 O) HELIX 1 AA1 SER A 26 ASP A 36 1 11 HELIX 2 AA2 GLY A 43 THR A 54 1 12 HELIX 3 AA3 ARG A 58 ALA A 73 1 16 HELIX 4 AA4 THR A 75 ALA A 90 1 16 HELIX 5 AA5 VAL A 116 ALA A 129 1 14 HELIX 6 AA6 ALA A 148 LEU A 154 1 7 HELIX 7 AA7 GLY A 161 GLY A 173 1 13 HELIX 8 AA8 ALA A 179 HIS A 183 1 5 HELIX 9 AA9 TYR A 186 GLY A 197 1 12 HELIX 10 AB1 THR A 200 THR A 209 5 10 HELIX 11 AB2 PHE A 223 ARG A 237 1 15 HELIX 12 AB3 ASP A 275 GLY A 280 5 6 HELIX 13 AB4 GLN A 285 LEU A 289 5 5 HELIX 14 AB5 ASP A 293 GLY A 306 1 14 HELIX 15 AB6 GLY A 310 SER A 332 1 23 HELIX 16 AB7 TRP A 336 THR A 353 1 18 HELIX 17 AB8 GLY A 354 GLN A 369 1 16 HELIX 18 AB9 SER B 26 ASP B 36 1 11 HELIX 19 AC1 GLY B 43 THR B 54 1 12 HELIX 20 AC2 ARG B 58 ALA B 73 1 16 HELIX 21 AC3 THR B 75 ALA B 90 1 16 HELIX 22 AC4 VAL B 116 ALA B 129 1 14 HELIX 23 AC5 GLY B 146 LEU B 154 1 9 HELIX 24 AC6 GLY B 161 VAL B 172 1 12 HELIX 25 AC7 ALA B 179 HIS B 183 1 5 HELIX 26 AC8 TYR B 186 GLY B 197 1 12 HELIX 27 AC9 THR B 200 ASN B 203 5 4 HELIX 28 AD1 LEU B 204 THR B 209 1 6 HELIX 29 AD2 PHE B 223 ARG B 237 1 15 HELIX 30 AD3 ASP B 275 GLY B 280 5 6 HELIX 31 AD4 GLN B 285 LEU B 289 5 5 HELIX 32 AD5 ALA B 294 GLY B 306 1 13 HELIX 33 AD6 GLY B 310 GLY B 329 1 20 HELIX 34 AD7 GLU B 335 THR B 353 1 19 HELIX 35 AD8 GLY B 354 GLN B 369 1 16 SHEET 1 AA1 5 VAL A 103 GLY A 107 0 SHEET 2 AA1 5 ALA A 216 GLY A 220 1 O GLY A 220 N VAL A 106 SHEET 3 AA1 5 SER A 240 GLY A 246 1 O VAL A 244 N ILE A 219 SHEET 4 AA1 5 SER A 259 ALA A 265 -1 O VAL A 264 N VAL A 241 SHEET 5 AA1 5 SER A 268 PHE A 274 -1 O PHE A 274 N SER A 259 SHEET 1 AA2 2 VAL A 133 GLY A 137 0 SHEET 2 AA2 2 ILE A 174 PHE A 178 1 O GLY A 175 N LYS A 135 SHEET 1 AA3 5 VAL B 103 GLY B 107 0 SHEET 2 AA3 5 ALA B 216 GLY B 220 1 O GLY B 220 N VAL B 106 SHEET 3 AA3 5 SER B 240 GLY B 246 1 O LEU B 242 N ILE B 219 SHEET 4 AA3 5 SER B 259 ALA B 265 -1 O VAL B 264 N VAL B 241 SHEET 5 AA3 5 SER B 268 PHE B 274 -1 O PHE B 274 N SER B 259 SHEET 1 AA4 2 VAL B 133 GLY B 137 0 SHEET 2 AA4 2 ILE B 174 PHE B 178 1 O GLY B 175 N LYS B 135 SITE 1 AC1 19 HIS A 91 ASN A 138 ALA A 179 PRO A 180 SITE 2 AC1 19 ARG A 181 HIS A 183 PRO A 184 TYR A 186 SITE 3 AC1 19 ARG A 187 ALA A 190 ARG A 193 ARG A 194 SITE 4 AC1 19 GLY A 206 IMD A 401 IMD A 402 HOH A 503 SITE 5 AC1 19 HOH A 513 HOH A 561 HOH A 577 SITE 1 AC2 4 ASP A 159 ARG A 181 7P1 A 400 IMD A 402 SITE 1 AC3 4 ASP A 159 PHE A 178 7P1 A 400 IMD A 401 SITE 1 AC4 14 THR A 257 ARG A 283 MET B 86 ASN B 138 SITE 2 AC4 14 ALA B 179 PRO B 180 HIS B 183 TYR B 186 SITE 3 AC4 14 ARG B 187 ALA B 190 ARG B 193 IMD B 403 SITE 4 AC4 14 HOH B 526 HOH B 530 SITE 1 AC5 5 ALA B 46 TRP B 47 ASP B 50 GLU B 342 SITE 2 AC5 5 ARG B 346 SITE 1 AC6 8 ALA B 236 ARG B 237 LEU B 305 GLY B 306 SITE 2 AC6 8 GLY B 307 ILE B 351 ASP B 352 GLU B 357 SITE 1 AC7 3 HIS B 136 GLY B 206 7P1 B 400 CRYST1 94.467 78.039 102.945 90.00 111.00 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010586 0.000000 0.004064 0.00000 SCALE2 0.000000 0.012814 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010405 0.00000